Federated Hermes, Inc. Molecular Partners Ag Call Options Transaction History
Federated Hermes, Inc.
- $52.5 Billion
- Q3 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding MOLN
# of Institutions
7Shares Held
3.59MCall Options Held
0Put Options Held
0-
Suvretta Capital Management, LLC New York, NY2.22MShares$8.2 Million0.29% of portfolio
-
Bvf Inc San Francisco, CA1.35MShares$5 Million0.2% of portfolio
-
Ubs Group Ag10.2KShares$37,6340.0% of portfolio
-
Morgan Stanley New York, NY367Shares$1,3540.0% of portfolio
-
Bank Of America Corp Charlotte, NC157Shares$5790.0% of portfolio
About MOLECULAR PARTNERS AG
- Ticker MOLN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 32,514,000
- Market Cap $120M
- Description
- Molecular Partners AG operates as a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic proteins. Its products candidates include Abicipar, a DARPin therapeutic candidate, which is in Phase III clinical trials for the treatment of neovascular wet age-related macular degeneration, ...